JPH09188680A5 - - Google Patents
Info
- Publication number
- JPH09188680A5 JPH09188680A5 JP1996264860A JP26486096A JPH09188680A5 JP H09188680 A5 JPH09188680 A5 JP H09188680A5 JP 1996264860 A JP1996264860 A JP 1996264860A JP 26486096 A JP26486096 A JP 26486096A JP H09188680 A5 JPH09188680 A5 JP H09188680A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- formula
- pharmaceutical composition
- prophylactically
- infection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US480695P | 1995-10-06 | 1995-10-06 | |
| US869595P | 1995-12-15 | 1995-12-15 | |
| US60/004806 | 1995-12-15 | ||
| US60/008695 | 1995-12-15 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH09188680A JPH09188680A (ja) | 1997-07-22 |
| JPH09188680A5 true JPH09188680A5 (enExample) | 2004-10-14 |
Family
ID=26673503
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP8264860A Pending JPH09188680A (ja) | 1995-10-06 | 1996-10-04 | ８−アリールアルキル−及び８−アリールヘテロアルキル−５，１１−ジヒドロ−６Ｈ−ジピリド［３，２−ｂ：２’，３’−ｅ］［１，４］ジアゼピン及びＨＩＶ 感染症の予防または治療におけるそれらの使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US5705499A (enExample) |
| EP (1) | EP0767172B1 (enExample) |
| JP (1) | JPH09188680A (enExample) |
| AT (1) | ATE235495T1 (enExample) |
| DE (1) | DE69626915T2 (enExample) |
| DK (1) | DK0767172T3 (enExample) |
| ES (1) | ES2191075T3 (enExample) |
| PT (1) | PT767172E (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5747488A (en) * | 1996-01-30 | 1998-05-05 | Boehringer Ingelheim Pharmaceuticals, Inc. | 2-aryl-5,11-dihydro-6H-dipyrido 3,2-B:2',3'-E! 1, 4!diazepines and their use in the treatment of HIV infection |
| GB9715584D0 (en) * | 1997-07-23 | 1997-10-01 | Eisai Co Ltd | Compounds |
| UA71971C2 (en) | 1999-06-04 | 2005-01-17 | Agoron Pharmaceuticals Inc | Diaminothiazoles, composition based thereon, a method for modulation of protein kinases activity, a method for the treatment of diseases mediated by protein kinases |
| US6455554B1 (en) | 1999-06-07 | 2002-09-24 | Targacept, Inc. | Oxopyridinyl pharmaceutical compositions and methods for use |
| US7141581B2 (en) * | 1999-07-02 | 2006-11-28 | Agouron Pharmaceuticals, Inc. | Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use |
| TWI262914B (en) * | 1999-07-02 | 2006-10-01 | Agouron Pharma | Compounds and pharmaceutical compositions for inhibiting protein kinases |
| HN2001000008A (es) * | 2000-01-21 | 2003-12-11 | Inc Agouron Pharmaceuticals | Compuesto de amida y composiciones farmaceuticas para inhibir proteinquinasas, y su modo de empleo |
| BR0110302A (pt) | 2000-04-18 | 2003-01-14 | Agouron Pharma | Compostos de pirazol para inibição de proteìnas cinase, sal e pró-droga farmaceuticamente aceitável, metabólito farmaceuticamente ativo ou sal farmaceuticamente aceitável de metabólito, composição farmacêutica, método de tratamento de condição doentia em mamìferos mediada pela atividade de proteìna cinase, método de modulação ou inibição da atividade de um receptor de proteìna cinase |
| TWI270547B (en) * | 2000-06-16 | 2007-01-11 | Boehringer Ingelheim Ca Ltd | Non-nucleoside reverse transcriptase inhibitors |
| SI1294720T1 (sl) * | 2000-06-16 | 2006-08-31 | Boehringer Ingelheim Ca Ltd | Nenukleozidni inhibitorji reverzne transkriptaze |
| US6716836B2 (en) | 2001-03-22 | 2004-04-06 | Boehringer Ingelheim (Canada) Ltd. | Non-nucleoside reverse transcriptase inhibitors |
| US6673791B2 (en) * | 2001-07-30 | 2004-01-06 | Boehringer Ingelheim (Canada) Ltd. | Non-nucleoside reverse transcriptase inhibitors |
| US6706706B2 (en) | 2002-03-27 | 2004-03-16 | Boehringer Ingelheim International Gmbh | Non-nucleoside reverse transcriptase inhibitors |
| US6806265B2 (en) * | 2002-05-16 | 2004-10-19 | Boehringer Ingelheim International Gmbh | Non-nucleoside reverse transcriptase inhibitors |
| DE60306539T2 (de) * | 2002-09-19 | 2007-07-19 | Boehringer Ingelheim (Canada) Ltd., Laval | Nicht-nukleosidische inhibitoren der reverse transkriptase |
| WO2004026875A1 (en) * | 2002-09-19 | 2004-04-01 | Boehringer Ingelheim (Canada) Ltd. | Non-nucleoside reverse transcriptase inhibitors |
| US7384937B2 (en) | 2002-11-06 | 2008-06-10 | Bristol-Myers Squibb Co. | Fused heterocyclic compounds and use thereof |
| EP1610782A1 (en) * | 2003-03-27 | 2006-01-04 | Boehringer Ingelheim International GmbH | Antiviral combination of a dipyridodiazepinone and a further antiretroviral compound |
| EP1737852A2 (en) * | 2004-04-13 | 2007-01-03 | Icagen, Inc. | Polycyclic pyridines as potassium ion channel modulators |
| EP1781300A1 (en) | 2004-07-16 | 2007-05-09 | ProteoSys AG | Muscarinic antagonists with parp and sir modulatng activity as agents for inflammatory diseases |
| EP2387405A2 (en) | 2009-01-13 | 2011-11-23 | ProteoSys AG | Pirenzepine as an agent in cancer treatment |
| CA2968464A1 (en) | 2014-11-25 | 2016-06-02 | Bayer Pharma Aktiengesellschaft | Substituted pyridobenzodiazepinone-derivatives and use thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5366972A (en) * | 1989-04-20 | 1994-11-22 | Boehringer Ingelheim Pharmaceuticals, Inc. | 5,11-dihydro-6H-dipyrido(3,2-B:2',3'-E)(1,4)diazepines and their use in the prevention or treatment of HIV infection |
| CA2183571A1 (en) * | 1994-02-18 | 1995-08-24 | Karl D. Hargrave | 2-heteroaryl-5,11-dihydro-6h-dipyrido[3,2-b:2',3'-e][1,4]diazepines and their use in the prevention or treatment of hiv infection |
-
1996
- 1996-09-25 US US08/710,996 patent/US5705499A/en not_active Expired - Lifetime
- 1996-10-04 ES ES96115901T patent/ES2191075T3/es not_active Expired - Lifetime
- 1996-10-04 EP EP96115901A patent/EP0767172B1/en not_active Expired - Lifetime
- 1996-10-04 PT PT96115901T patent/PT767172E/pt unknown
- 1996-10-04 AT AT96115901T patent/ATE235495T1/de not_active IP Right Cessation
- 1996-10-04 JP JP8264860A patent/JPH09188680A/ja active Pending
- 1996-10-04 DE DE69626915T patent/DE69626915T2/de not_active Expired - Fee Related
- 1996-10-04 DK DK96115901T patent/DK0767172T3/da active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE218580T1 (de) | Cyclosporinderivate, deren herstellung und pharmazeutische zusammensetzungen | |
| ATE218582T1 (de) | Cyclosporinderivate, deren herstellung und pharmazeutische zusammensetzungen | |
| FI973518A7 (fi) | Piperidinoalkanoliyhdistettä tai sen farmaseuttisesti hyväksyttävää suolaa sisltävä farmaseuttinen koostumus kiinteässä yksikköannosmuodossa | |
| RU94041223A (ru) | Средство для лечения мотонейроновых заболеваний | |
| GEP20002298B (en) | Benzimidazole Derivatives, Method of Their Production, Pharmaceutical Composition Containing the Same and Method for Its Treatment | |
| EA199600104A1 (ru) | Повышенная биодоступность биологически активных соединений при связывании с производными полипирролкарбоксамидонафталиновой кислоты | |
| EE200000535A (et) | Triasendatud 1,3,5-triasiini derivaatide kasutamine ravimi valmistamiseks, mis on ette nähtud HIV nakkuse raviks, ühend, seda sisaldav farmatseutiline kompositsioon, meetod ühendi ja kompositsiooni valmistamiseks ning kombineeritud preparaat kasutami | |
| DE69631609D1 (en) | Tricyclische erythromycinderivate | |
| JP2002522501A5 (enExample) | ||
| CA2307788A1 (en) | 2-halo-6-o-substituted ketolide derivatives | |
| NZ514558A (en) | Viral treatment | |
| BR9503572A (pt) | Composto composiçao farmaceutica e método de tratamento ou prevençao de uma doença | |
| ZA979647B (en) | Heterocyclic compounds, compositions and uses. | |
| EE03514B1 (et) | Ühendite kombinatsioon HIV infektsiooni või AIDS-i raviks, selle kasutamine ja farmatseutiline kompositsioon | |
| CA2218643A1 (en) | Oral pharmaceutical composition of piperidinoalkanol compounds in solution form | |
| ZA979650B (en) | Heterocyclic compounds, compositions and uses. | |
| AP9801235A0 (en) | Erythromycin derivatives. | |
| ZA979645B (en) | Heterocyclic compounds, compositions and uses. | |
| CA2190952A1 (en) | Use of a naphthalenesulfonic acid compound for inhibiting retroviral infection | |
| WO2001007029A3 (en) | Substituted guanidines and the use thereof | |
| MY133222A (en) | Method of treating glaucoma and ischemic retinopathy | |
| AR015458A1 (es) | Compuestos de tetrahidrofurano, y composicion farmaceutica que lo contiene. | |
| HU9502509D0 (en) | Use of 1,4-dihydropyridine-3,5-dicarboxylic-acid-esters as active component of pharmaceutical compositions | |
| RU93058386A (ru) | Противовирусная комбинация, содержащая неуклеозидный аналог, фармацевтическая композиция, способ лечения | |
| DE60022047D1 (de) | Antivirale therapie |